JENNIFER RUSSELL: Open Payments
NPI 1659791986 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 21 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $65 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $240 |
| GENZYME CORPORATION | 2 | $69 |
| SOBI, INC | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| BeOne Medicines USA, Inc. | 2 | $48 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| BeiGene USA, Inc. | 1 | $19 |
Products named: CALQUENCE, BRUKINSA, Doptelet, Fabhalta, SARCLISA, AYVAKIT.
Industry payments across CA — which companies pay providers there.
